Additionally, treatment with antioxidants, mitochondrial superoxide dismutase mimetics, and AT1r blockers decreased vascular O2 production and attenuated development of HT in SHR (Park et al. 2002; Rodriguez-Iturbe et al. 2003; Shokoji et al. 2003). Here, AGTR1 is linked to hematocrit.